XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share data):
 Three Months Ended
March 31,
 20222021
Net loss$(12,414)$(8,418)
Weighted average common shares outstanding, basic and diluted95,924 98,581 
Net loss per share, basic and diluted$(0.13)$(0.09)
The following table presents the number of anti-dilutive shares excluded from the calculation of diluted loss per share at March 31, 2022 and 2021 (in thousands):
 March 31,
 20222021
Options to purchase common stock5,720 9,855 
Common stock warrants— 510 
Non-vested restricted stock unit awards11,490 7,225 
Total shares excluded from net loss per share17,210 17,590 
Share Repurchase Program

In July 2020, the Company’s board of directors authorized an open market stock repurchase program (the “Program”) of up to $75 million to allow for the repurchase of shares of the Company’s common stock through September 30, 2022. In May 2021, the Company’s board of directors increased the authorization of the Program by an additional $75 million, bringing the total authorization to $150 million. The timing and amount of any repurchases will be determined by Company management based on its evaluation of market conditions and other factors. Repurchases of the Company’s common stock may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws, open market purchases, privately-negotiated transactions, block purchases or otherwise in accordance with applicable federal securities laws. The Program may be suspended or discontinued at any time and does not obligate the Company to purchase any minimum number of shares. During the three months ended March 31, 2022 the Company repurchased and retired a total of 3.1 million shares under the Program for $11.0 million. As of March 31, 2022, the Company had a remaining authorization of $64.5 million for future share repurchases.